Get the Stockscreener App
16.07
8.22%
-1.44
After Hours:
16.07
Invizyne Technologies Inc stock is traded at $16.07, with a volume of 8,515.
It is down -8.22% in the last 24 hours and up +21.10% over the past month.
Invizyne Technologies Inc is redefining biomanufacturing by leveraging cell-free multi-step enzyme-based systems to efficiently transform natural or renewable resources into highly sought-after chemicals. It believes that its biomanufacturing platform, known as SimplePath, will be a significant alternative to the current methods of chemical compound production, which are generally chemical synthesis, natural extraction, and synthetic biology. its objective with SimplePath is to enable the efficient production of a diverse range of chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform consists of a series of modular cascading enzyme-based biomanufacturing systems that leverage natural processes to perform complex chemical conversions.
See More
Previous Close:
$17.51
Open:
$17.5
24h Volume:
8,515
Relative Volume:
0.27
Market Cap:
$153.41M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-4.12%
1M Performance:
+21.10%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$16.07
$17.50
1-Week Range:
$15.81
$18.87
52-Week Range:
$10.00
$23.00
Invizyne Technologies Inc Stock (IZTC) Company Profile
Name
Invizyne Technologies Inc
Sector
Industry
Phone
(626) - 415 - 1488
Address
750 ROYAL OAKS DR, MONROVIA
Compare IZTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IZTC
Invizyne Technologies Inc
|
16.07 | 153.41M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.23 | 122.13B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
710.00 | 78.30B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
646.64 | 39.73B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
276.19 | 35.50B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.61 | 28.47B | 3.30B | -501.07M | 1.03B | -2.1146 |
Invizyne Technologies Inc Stock (IZTC) Latest News
Invizyne technologies CEO Michael Heltzen buys $20,345 in stock - MSN
Invizyne technologies CEO Michael Heltzen buys $20,345 in stock By Investing.com - Investing.com Australia
Investors on Edge! What Invizyne’s Market Entry Means for Biotech’s Future - Jomfruland.net
Invizyne Technologies Inc.'s (NASDAQ:IZTC) Quiet Period To End on December 23rd - MarketBeat
Invizyne Technologies Inc.’s Quiet Period Set To Expire on December 23rd (NASDAQ:IZTC) - Defense World
Invizyne Technologies selected for $2 million project to advance SAF capabilities - Biomass Magazine
Invizyne Technologies Inc trading halted, volatility trading pause - TipRanks
MDB Capital Holdings Provides Third Quarter 2024 Update - Marketscreener.com
Invizyne Technologies (IZTC) Income Statement & Balance Sheet 2024 - MarketBeat
Opening Day: Invizyne Technologies jumps after IPO - MSN
Invizyne technologies CEO acquires shares worth $22,022 By Investing.com - Investing.com Australia
Invizyne technologies CEO acquires shares worth $22,022 - Investing.com
Faculty in the News – James Bowie - UCLA – Chemistry and Biochemistry
Invizyne Technologies Selected for $2 Million Project to Advance Sustainable Aviation Fuel Capabilities - Marketscreener.com
Invizyne Technologies, Inc. Selects for $2 Million Project to Advance Sustainable Aviation Fuel Capabilities - Marketscreener.com
Invizyne Technologies Completes IPO, Raises $14 Million in Net Proceeds - Defense World
Invizyne Technologies (IZTC) Stock Chart and Price History 2024 - MarketBeat
U.S. IPO Weekly Recap: One Micro-Cap Lists And More Enter Pipeline, As Peak Resources Postpones Its IPO - Seeking Alpha
Invizyne Technologies Announces Closing of Initial Public Offering - Marketscreener.com
Invizyne Technologies Completes $15M IPO, Makes NASDAQ Debut Under IZTC | MDBH Stock News - StockTitan
Invizyne Technologies stock climbs 13% following $15M IPO - MSN
Invizyne’s Nasdaq IPO Marks New Era of Biomanufacturing - GlobeNewswire
Invizyne's Nasdaq IPO Marks New Era of Biomanufacturing - Quantisnow
Invizyne Technologies Opens At $11.10, IPO Priced At $8 By Investing.com - Investing.com Canada
Invizyne Technologies Begins Trading on NASDAQ - GlobeNewswire
Invizyne Technologies prices $15M U.S. IPO - MSN
Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024 - The Bakersfield Californian
Invizyne Technologies prices $15M U.S. IPO (Pending:IZTC.) - Seeking Alpha
Invizyne Technologies Launches $15M IPO, Sets Nasdaq Debut Under 'IZTC' Symbol | MDBH Stock News - StockTitan
TSX Health Care Capped Index (TTHC) QuotePress Release - The Globe and Mail
ULSD NY Harbor (HON24) Quote - The Globe and Mail
IZTC IPO NewsBiomanufacturing company Invizyne Technologies revises terms ahead of $15 million IPO - Renaissance Capital
Biomanufacturing company Invizyne Technologies cuts share offering by 13% and adds rights ahead of $15 million IPO - Renaissance Capital
The cold truth: B100 with Optimus Technologies work at -30 °F - Biodiesel Magazine
MDB Capital Announces Record Date and Expected Timing for Initial Public Offering for Invizyne Technologies - GlobeNewswire
Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq - GlobeNewswire
MDB Capital Holdings Year-End Update - GlobeNewswire
Invizyne Technologies Announces Filing of Registration Statement for Proposed Offering and Listing on Nasdaq - GlobeNewswire
Michael Burns Joins Invizyne as Executive Vice President of Energy Transition - GlobeNewswire
Invizyne Selected by Shell GameChanger Accelerator Powered by NREL for Sixth Cohort - GlobeNewswire
Invizyne Awarded Additional $3.77 Million Grant from U.S. Department of Energy - GlobeNewswire
MDBHMDB Capital Holdings, LLC Latest Stock News & Market Updates - StockTitan
Japan plans to implement SAF mandate by 2030 - Biodiesel Magazine
Cavitation Technologies to supply LPN system to biodiesel plant - Biodiesel Magazine
Haldor Topsoe technology to be installed at 2 SAF biorefineries - Biodiesel Magazine
Major advance in biochemistry holds promise for biofuels - University of California
Major advance in ‘synthetic biochemistry’ holds promise for industrial products and biofuels - UCLA Newsroom
Invizyne Technologies Inc Stock (IZTC) Financials Data
There is no financial data for Invizyne Technologies Inc (IZTC). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Invizyne Technologies Inc Stock (IZTC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Heltzen Michael | Chief Executive Officer |
Jan 16 '25 |
Buy |
10.72 |
121 |
1,297 |
2,105 |
| Heltzen Michael | Chief Executive Officer |
Nov 15 '24 |
Buy |
11.10 |
1,984 |
22,022 |
1,984 |
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):